Menu

Natus Medical Incorporated NTUS

Full chart Compare
Set alert

Price alert · NTUS

All alert types
32.96 +32.96

Day range unavailable

52-week range unavailable

Revenue & Expenses

Revenue by
Neurology Products → Revenue: $284.77MRevenue → Gross Profit: $273.68MGross Profit → Net Income: $13.18MGross Profit → Selling, General & Admin: $168.77MGross Profit → Research & Development: $56.31MRevenue → Cost of Revenue: $199.76MGross Profit → Other Operating Expenses: $17.13MGross Profit → Interest Expense: $1.87MGross Profit → Other Expenses: $10.25MGross Profit → Income Tax: $6.18MNewborn Care Products → Revenue: $105.02MOtometricsProducts → Revenue: $83.65MGross Profit$273.68MCost of Revenue$199.76MNet Income$13.18MSelling, General & Admin$168.77MResearch & Development$56.31MOther Operating Expenses$17.13MInterest Expense$1.87MOther Expenses$10.25MIncome Tax$6.18MRevenue$473.44MNeurology Products$284.77MNewborn Care Products$105.02MOtometricsProducts$83.65M

Latest period ending Dec 31, 2021 · select a line to chart its full history

NTUS annual income statement
Fiscal yearFY 2021 Dec 31, 2021FY 2020 Dec 31, 2020FY 2019 Dec 31, 2019FY 2018 Dec 31, 2018FY 2017 Dec 31, 2017
473.44M415.68M495.18M530.89M500.97M
273.68M216.53M291.71M304.01M281.21M
23.78M-20.19M-15.67M-24.56M8.72M
13.18M-16.61M-15.67M-22.93M-20.29M
0.39-0.49-0.47-0.69-0.62
NTUS annual balance sheet
Fiscal yearFY 2021 Dec 31, 2021FY 2020 Dec 31, 2020FY 2019 Dec 31, 2019FY 2018 Dec 31, 2018FY 2017 Dec 31, 2017
75.59M82.08M63.30M56.37M88.95M
564.29M600.39M622.53M638.14M709.92M
139.54M189.30M206.40M239.70M287.82M
11.53M71.58M72.59M104.47M154.28M
424.75M411.09M416.12M398.44M422.10M
NTUS annual cash flow
Fiscal yearFY 2021 Dec 31, 2021FY 2020 Dec 31, 2020FY 2019 Dec 31, 2019FY 2018 Dec 31, 2018FY 2017 Dec 31, 2017
63.99M34.43M60.06M33.02M19.73M
-1.95M-12.61M-5.34M-8.39M-160.94M
-60.66M-10.88M-48.53M-49.51M5.83M
-946.00K-8.61M-5.33M-7.88M-4.07M
-6.49M18.79M6.92M-32.58M-124.60M